Company Alkem Laboratories Limited

Equities

ALKEM

INE540L01014

Pharmaceuticals

Market Closed - NSE India S.E. 07:43:53 2024-07-12 am EDT 5-day change 1st Jan Change
5,199 INR -0.01% Intraday chart for Alkem Laboratories Limited +2.67% -0.07%

Business Summary

Alkem Laboratories Ltd. is an India-based pharmaceutical company with global operations, engaged in the development, manufacturing and sale of pharmaceutical and nutraceutical products. The Company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets. It has a portfolio of more than 800 brands in India. The Company also has a presence in more than 40 international markets, with the United States being its key focus market. Its offerings include therapies, Rx products and Alkem generic. Its therapy offerings include anti-infective, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory, rheumatology and urology. Its product portfolio also includes mega-brands such as Clavam, Pan, Pan-D, and Taxim-O. Under the Alkem Generics cluster there are four divisions: Futura, Maxxio, Novokem and Alkem Healthcare.

Number of employees: 16,871

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceutical and Related Products
100.0 %
106,342 100.0 % 115,993 100.0 % +9.08%

Sales per region

INR in Million2022Weight2023Weight Delta
India
70.3 %
75,266 70.8 % 81,600 70.3 % +8.41%
United States
21.7 %
23,291 21.9 % 25,134 21.7 % +7.91%
Other Countries
8.0 %
7,785 7.3 % 9,259 8.0 % +18.94%

Managers

Managers TitleAgeSince
Chief Executive Officer - 23-09-21
Director of Finance/CFO - Jan. 31
Compliance Officer 54 06-10-31
Director/Board Member 42 13-08-08
Corporate Officer/Principal - 07-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 60 -
Chief Executive Officer 84 73-08-07
Director/Board Member 69 15-06-28
Director/Board Member 42 13-08-08
Director/Board Member 61 87-12-31
Director/Board Member - 11-12-31
Director/Board Member 42 19-11-10
Director/Board Member 71 20-03-15
Director/Board Member - 21-12-19
- -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 119,550,000 33,871,246 ( 28.33 %) 0 28.33 %

Shareholders

NameEquities%Valuation
25,285,600 21.15 % 1 514 M ₹
8,695,360 7.272 % 520 M ₹
7,682,000 6.425 % 460 M ₹
Singh Dhananjay Kumar /Estate Of/
5.391 %
6,445,745 5.391 % 386 M ₹
5,138,220 4.297 % 308 M ₹
3,423,312 2.863 % 205 M ₹
3,034,535 2.538 % 182 M ₹
2,937,740 2.457 % 176 M ₹
2,835,342 2.371 % 170 M ₹
Alok Kumar
2.312 %
2,764,719 2.312 % 165 M ₹

Company contact information

Alkem Laboratories Ltd.

Devashish Building, Alkem House Senapati Bapat Marg

400013, Mumbai

+91 22 3982 9999

http://www.alkemlabs.com
address Alkem Laboratories Limited(ALKEM)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Generic
Pharmaceuticals: Major
S&B Pharma LLC
The Pharma Network LLP

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
5,199 INR
Average target price
5,202 INR
Spread / Average Target
+0.06%
Consensus
  1. Stock Market
  2. Equities
  3. ALKEM Stock
  4. Company Alkem Laboratories Limited